Vasundhara Rasayans Limited

VRL6

INE406F01010

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:57 2024-06-20 am EDT			5-day change	1st Jan Change
245.7 ^INR	+4.24%		+9.20%	+24.41%

May. 28	Vasundhara Rasayans Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
Apr. 04	Vasundhara Rasayans Limited Announces Resignation of Ashish Kedia as Director	CI

Vasundhara Rasayans Limited Recommends the Dividend for the Financial Year Ended March 31, 2022

August 25, 2022 at 03:54 am EDT

Vasundhara Rasayans Limited at the meeting of Board of Directors of 25 August, 2022 recommended the Board approved and declared dividend of INR 1 per Equity Share of the Company for the financial year ended 31st March, 2022.

Latest news about Vasundhara Rasayans Limited

Vasundhara Rasayans Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 28	CI
Vasundhara Rasayans Limited Announces Resignation of Ashish Kedia as Director	Apr. 04	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Vasundhara Rasayans Limited Approves Dividend for the Financial Year Ended March 31, 2023	23-08-29	CI
Vasundhara Rasayans Limited Proposes Dividend for the Financial Year Ended March 31, 2023	23-08-21	CI
Vasundhara Rasayans Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Vasundhara Rasayans Limited Announces Board Appointments	23-08-01	CI
Vasundhara Rasayans Limited Announces Dividend for the Financial Year Ended March 31, 2023	23-08-01	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
Vasundhara Rasayans Limited Announces Resignation of Rajesh Kumar Jain as Independent Director	23-05-25	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Vasundhara Rasayans Limited Declares Dividend for the Financial Year Ended March 31, 2022	22-10-01	CI
Vasundhara Rasayans Restarts Operations at Unit in Maharashtra, India	22-09-23	MT
Vasundhara Rasayans Limited Proposes Dividend for the Financial Year Ended 31 March 2022	22-09-06	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-09-06	CI
Vasundhara Rasayans Shuts Down Operations on State Pollution Control Board Order	22-09-05	MT
Vasundhara Rasayans Board Declares Dividend for Fiscal 2022	22-08-25	MT
Vasundhara Rasayans Limited Recommends the Dividend for the Financial Year Ended March 31, 2022	22-08-25	CI
Vasundhara Rasayans Limited Recommends Dividend for the Financial Year Ended 31 March 2022	22-08-17	CI
Vasundhara Rasayans Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI
Vasundhara Rasayans' Net Profit Soars in Fiscal Q4	22-06-09	MT
Vasundhara Rasayans Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Vasundhara Rasayans Limited Approves Dividend for the Financial Year Ended March 31, 2021	21-10-01	CI

Chart Vasundhara Rasayans Limited

Duration

Period

More charts

Company Profile

Vasundhara Rasayans Limited is an India-based company. The Company is engaged in manufacturing and exporting of antacid therapeutic category of Active Pharma Ingredients (API). In addition to the API manufacturing the Company is also operating an API intermediate plant to handle organic products with its specialized Friedel Craft reaction facility. It offers a range of products under Antacid API, such as Aluminum Hydroxide Gel, Magnesium Hydroxide, Magaldrate (Aluminum Magnesium Hydroxide Sulphate), Magnesium Trisilicate, Magnesium Silicate, and Aluminum Phosphate. These products are offered in paste, powder, and micronized grade powder, which is used to make liquid antacid formulations in place of conventional paste form of the products. Its product for Lake Color consists of Aluminum Hydroxide Gel Low Heavy Lead Content. Its product offering other applications of water treatment and Aluminum Salts includes Aluminum Hydroxide Amorphous, Aluminum Sulphate, and Poly Aluminum Chloride.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VASUNDHARA RASAYANS LIMITED	+24.41%	8.98M
ELI LILLY AND COMPANY	+54.65%	803B
JOHNSON & JOHNSON	-6.72%	351B
MERCK & CO., INC.	+18.61%	324B
ABBVIE INC.	+11.01%	303B
ASTRAZENECA PLC	+16.96%	243B
ROCHE HOLDING AG	+2.25%	228B
NOVARTIS AG	+11.15%	217B
AMGEN INC.	+6.48%	164B
PFIZER, INC.	-3.81%	155B